Showing 1651-1660 of 4065 results for "".
Applying Advances in Practice: Case-Based Look at Selecting Therapy for Cushing Syndrome
https://reachmd.com/programs/cme/case-selecting-therapy-cushing-syndrome/50063/Cushing syndrome has seen exciting advances over the last couple of years, but how do they translate into improved patient care? Let’s dig into a couple of cases and discuss!Optimizing the Care and Quality of Life for Patients with ADPKD – Part 1: Detection and Diagnosis
https://reachmd.com/programs/cme/clinical-significance-imaging-management-adpkd/12677/What are effective strategies for detecting and diagnosing patients who are at risk of autosomal dominant polycystic kidney disease?Therapies & Vaccines on the Horizon for COVID-19
https://reachmd.com/programs/the-drug-report/therapies-vaccines-on-the-horizon-for-covid-19/11288/After much research activity has been devoted to finding a vaccine and cure for COVID-19, could there finally be hope amid this global pandemic?Drug Shortages During the COVID-19 Pandemic
https://reachmd.com/programs/the-drug-report/drug-shortages-during-the-covid-19-pandemic/11440/Multiple sources are reporting shortages of drugs needed to help COVID-19 patients on medical ventilation. Here’s what’s being done in response.Reimagining Lung Cancer Treatment: A Journey Through New and Emerging Therapeutics Related to the Care of Patients with Small Cell and Non-Small Cell Lung Cancer
https://reachmd.com/programs/cme/reimagining-lung-cancer-treatment-a-journey-through-new-and-emerging-therapeutics-related-to-the-care-of-patients-with-small-cell-and-non-small-cell-lung-cancer/35653/Reimagine lung cancer care—discover how new and emerging therapies are reshaping the treatment of SCLC and NSCLCA Guide for Off-Label Use of Treatments for COVID-19 from the ASHP
https://reachmd.com/programs/the-drug-report/a-guide-for-off-label-use-of-treatments-for-covid-19-from-the-ashp/11412/Recommendations for using experimental treatments during the COVID-19 pandemic were recently published. Here’s what they say.CDC - Reducing Severe Traumatic Brain Injury in the US, Part 3
https://reachmd.com/programs/grand-rounds-nation/cdc-reducing-severe-traumatic-brain-injury-in-the-us-part-3/6563/Traumatic brain injury, or TBI, is a serious public health problem that affects approximately 1.7 million Americans every year. Of all injury deaths in our country, one in three cases are TBI-related, and an estimated 5.3 million Americans are living with a TBI-related disability. Beyond the potentiCDC - Lyme Disease: Challenges and Innovations, Part 3
https://reachmd.com/programs/grand-rounds-nation/cdc-lyme-disease-challenges-and-innovations-part-3/6485/Lyme disease is one of the most rapidly emerging infectious diseases in North America and Europe. In 2009, nearly 30,000 confirmed and more than 8,500 probable cases of Lyme disease were reported to the CDC in the United States alone. Named after a small Connecticut town, Lyme disease is transmittedCDC - Sodium Reduction: Time for Choice, Part 3
https://reachmd.com/programs/grand-rounds-nation/cdc-sodium-reduction-time-for-choice-part-3/6439/The vast majority of US adults consume more than double the recommended maximum of sodium, which is a direct cause of hypertension, a condition that affects nearly 1 in 3 Americans. Hypertension is not only a major contributor to cardiovascular disease (CVD), disability, and health disparities, butCDC - TB & HIV: A Deadly Duo, Part 1
https://reachmd.com/programs/grand-rounds-nation/cdc-tb-hiv-a-deadly-duo-part-1/6390/The CDC commemorates Dr. Robert Koch's 1882 discovery of Mycobacterium tuberculosis, the bacteria that causes TB. Over the past 129 years, history has witnessed many advances over in TB control. Through the intervention efforts of CDC, USAID, WHO's Stop TB Partnership, and many others, TB death rate